BMS-5,
1338247-35-0,
LIMKi 3,
BMS 5,
N-(5-(1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide,
N-[5-[2-(2,6-dichlorophenyl)-5-(difluoromethyl)pyrazol-3-yl]-1,3-thiazol-2-yl]-2-methylpropanamide,
N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methylpropanamide,
N-{5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-1,3-thiazol-2-yl}-2-methylpropanamide,
LIMKi3,
LIM Kinase Inhibitor I,
C17H14Cl2F2N4OS,
GTPL9839,
CHEMBL2141887,
SCHEMBL15543888,
EX-A934,
SYN1024,
CHEBI:138670,
HMS3244I07,
HMS3244I08,
HMS3244J07,
BCP17223,
MFCD17019327,
RS0051,
ZINC72232826,
AKOS024458322,
CS-5617,
NCGC00263197-01,
NCGC00263197-03,
AK547236,
AS-16195,
HY-18305,
B7707,
FT-0700442,
J-523083,
BMS3,
A12839,
745053-65-0,